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Abstract
Aim: Antibiotic drugs are most frequently used by 0- to 4-year-old children. We performed a
cross-sectional study in the Netherlands using a pharmacy prescription database to investigate the
use, dose and course length of antibiotic drugs in 0- to 4-year-olds.
Methods: We used a database with pharmacy drug-dispensing data. We investigated all prescriptions
of systemic antibiotics prescribed in the years 2002–2006 for children of 0–4 years of age.
Prescriptions for children under the age of 3 months were excluded.
Results: Children of 9–12 months of age received more antibiotics than children in other age groups.
In the 3- to 6-month-olds, amoxicillin was prescribed in 75.2% of the cases. This percentage was
50.4% in the 4-year-olds. The contribution of other broad-spectrum antibiotics increased with age
(clarithromycin and amoxicillin⁄clavulanic acid). Small-spectrum penicillins were prescribed less often
than the broad-spectrum antibiotics. From the prescriptions of the ﬁve most used drugs, 97.6% were
within the recommended dose range. Most course lengths corresponded with the guidelines. Of the
prescriptions, 3.9% were unlicensed or off-label.
Conclusion: Within the group of 0- to 4-year-old children, most antibiotics were used by 9- to 12-month-olds.
The doses and course lengths were mostly correct, but the choice of antibiotics was not according to the
guidelines. Young children received unlicensed and off-label prescribed antibiotics.
INTRODUCTION
Antibiotics are the drugs most commonly prescribed in chil-
dren (1–3). The age group of 0- to 4-year-olds uses the most
antibiotic drugs: yearly, 29% has at least one antibiotic drug
prescribed (4). This youngest age group could cause prob-
lems in prescribing, because not all drugs are tested and
licensed for this age group, and differences in dosing may
result from metabolism, weights and diseases (5).
There are few studies about antibiotic drug use in the
youngest children. Several European studies found that
the highest use of antibiotics is in 1- to 6-year-olds (6–9).
The kinds of antibiotic drugs varied per country.
Not all antibiotics are registered for use in young children.
Some are unlicensed (e.g. a formulation prepared in the
pharmacy) or are prescribed off-label (e.g. a licensed drug
not registered for use under a certain age). A Dutch study
investigating unlicensed and off-label use of drugs found
that, out of all the prescriptions for children, 16.6% were
unlicensed, and 20.6% were off-label. The 0- to 1-year-old
age group had the highest chance of receiving unlicensed
or off-label drugs (10). Comparable ﬁgures are found in a
second Dutch study investigating general practitioner (GP)
prescriptions (11). Obviously, this means that prescribing
outside the marketing authorization takes place, but it is not
knownto whatextent this concerns antibiotic drugs.
In young children, the dosage is usually calculated by
weight or body surface area (12,13). It is not known whether
this is common practice. A Scottish study found that 11.8%
of children aged 0–4 years were prescribed an antibiotic in
lower doses than recommended (14). In daily practice, an
antibiotic course could be repeated after a few months or
half a year, without taking into account that the child has
grown.
We performed a cross-sectional study, using a pharmacy
prescription database, to ﬁnd answers to the following ques-
tions:
How many and what kinds of antibiotic drugs are used by
0- to 4-year-olds, and what are the differences between the
ages within this group?
Do the types of drugs, the dosages and the course lengths
correspondwith theDutchguidelines,andhowoftenareun-
licensedandoff-labelantibioticsprescribedtothisgroup?
METHODS
In this study, information on drug use was obtained
from the IADB.nl database (University of Groningen,
the Netherlands). The database contained pharmacy-
dispensing data from 55 community pharmacies in the
Netherlands. Dutch patients usually register at a single
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to provide an almost complete listing of the subject’s pre-
scribed drugs (15). Pharmacy data contain, among other
data, information on the name of the drug dispensed,
Anatomical Therapeutical Chemical (ATC) classiﬁcation,
date of prescription, number of days the drug was prescribed
and number of deﬁned daily doses (DDDs) based on the
deﬁnition by the World Health Organization (WHO) (16).
The use of over-the-counter (OTC) drugs and in-hospital
prescriptions are not included. The database covers a pop-
ulation of 500 000 people since 1999, of whom 120 000 are
individuals younger than 19 years of age, and is representa-
tive for the Dutch population in terms of drug use.
We selected all prescriptions of systemic antibiotics (ATC
code J01) prescribed in the years 2002–2006 for children of
0–4 years of age. Prescriptions for children under the age
of 3 months were excluded because of the special indica-
tions, low number of prescriptions in this age group and the
fact that these children are mostly treated in hospital when
they have infections. The age groups are classiﬁed in dif-
ferent ways. For determining and comparing the number of
prescriptions, we used age groups with 3-month increments.
The types of antibiotics were investigated in the age
groups: 3–6 months, 6–12 months, 1 year (that means
12-month-old till the day before the second birthday) and 2,
3 and 4 years.
Toexaminethe lengthanddose ofthe courses, weselected
all prescriptions of the ﬁve most frequently prescribed drugs
and excluded injections and prescriptions for which the dose
was unknown.
The lengths of the courses were determined by dividing
the amount prescribed by the daily dose.
For the dose examination, courses longer than the max-
imum mentioned in the guidelines were excluded in order
to avoid prophylactic multiple continuous antibiotic pre-
scribing. The age groups used here were 3–6 months, 6–12
months, 1 year and 2, 3 and 4 years. To compare the actual
prescription with the recommended dose, we used recent
ﬁgures based on growth change in the Netherlands (17) and
calculated for every age group the minimum and maximum
dose according to the Dutch guidelines. For the weights, we
used a range of 2 standard deviation (SD). Therefore, 95%
of all possible weights were included in each age group. The
dose of every prescription was examined based on its being
within the recommended dose range.
The guidelines used were the Standards of the Dutch
College of General Practitioners (NHG) (18), Blauw-
druk Pediatrische Antimicrobie ¨le Therapie (Blueprint
Paediatric Antimicrobial Therapy) (13) and the web-
site http://www.kinderformularium.nl, a website from the
Nederlands Kenniscentrum voor Farmacotherapie bij
Kinderen (NKFK; Netherlands Expertise centre of Pharma-
cotherapy in Children) (12).
The drug license information was obtained from the sum-
mary of product characteristics available on the website of
the Dutch Medicines Evaluation Board (http://www.cbg-
meb.nl) (19). In this study, we distinguished the following
terms to indicate the prescriptions:
• ‘Unlicensed’meansthattheproducthasnolicenseinthe
Netherlands at all: for example, in the pharmacy-prepared
formulations.
• ‘Off-label’ means that the product is licensed but not for
this indication orage.
• ‘Unregistered’ combines both terms: the prescription is
not licensed or is off-label.
For the analysis and statistics of the data, Microsoft
 
Ofﬁce Excel 2003 (Microsoft
  cooperation, Seattle, WA,
USA) and R version 2.6.2 (Free Software; Free Software
Foundation, Boston, MA, USA) were used.
RESULTS
Fromthedatabase,76 212prescriptionsfor30 730children
were selected. After exclusion of the prescriptions for chil-
dren younger than 3 months, 75 341 remained. Of these,
87.6% were prescribed by GPs, and 12.4% by different
specialists, who could not be separately identiﬁed by the
database.Oftheprescriptions,53.6%wereforboys.
Figure 1 shows the number of antibiotic prescriptions per
age group. The 9- to 12-month-olds received the most pre-
scriptions. Between 4 and 4.5 years, there was a small peak
in the number of prescriptions.
In Table 1, the proportions of the different antibiotics are
presented. The ﬁve most prescribed drugs were amoxicillin,
amoxicillin⁄clavulanic acid, azithromycin, clarithromycin
and cotrimoxazole (sulfamethoxazole⁄trimethoprim). In the
ﬁrst year, amoxicillin was used for 73–75%, but also other
antibiotics, mainly clarithromycin and amoxicillin with
clavulanic acid, were used. A trend towards less amoxicillin
and more of other antibiotic drugs appeared with increase
in age. The black cells in the table represent prescriptions
that were prescribed unlicensed or off-label. A part of the
group ‘miscellaneous drugs’ is also prescribed unlicensed
or off-label, such as ciproﬂoxacin and tetracycline. In total,
Figure 1 Number of antibiotic prescriptions per age category.
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and 0.9% off-label), mainly nitrofurantoin or trimethoprim
(3.0%). The age groups under 1 year of age had the highest
percentageof unregisteredprescriptions.
For the examination of the doses and course lengths pre-
scriptions of injections and products for respiratory use and
for which the daily dose was not known were excluded.
The prescriptions with the ﬁve most prescribed drugs were
selected.
For the dose examination, the courses of amoxicillin
and clarithromycin for more than 14 days, of amoxi-
cillin⁄clavulanic acid and cotrimoxazole for more than
10 days and of azithromycin for more than 5 days were
excluded. The doses of the remaining 59 712 courses were
examined. Of these prescriptions, 97.6% had a correct dose,
2.0% had a lower dose than recommended and 0.4% had
a higher dose. Figure 2 shows that the prescriptions of spe-
cialists had more often a too low or a too high dose, but still
93.0% of the prescriptions fell in the recommended dose
range. Cotrimoxazole was prescribed more often under the
minimum dose than the other drugs.
In Figure 3, the course lengths of the prescriptions of the
ﬁve most used drugs (n ¼ 66 063) are presented. The graphs
show that the most used course length for amoxicillin and
amoxicillin⁄clavulanic acid was 7 days, which is the median.
The course length for most azithromycin prescriptions was
3 days; the median was 4 days. The most used course length
for clarithromycin was 12 days, and so was the median. For
cotrimoxazole, the most used course length was 10 days,
with a medianof 16days.
DISCUSSION
Main results
For the 0- to 4-year-old group, most antibiotic drugs were
prescribed between the age of 9 and 12 months, and the least
were prescribed between 3 and 6 months. After reaching the
ageof1 year,the use ofantibiotics decreased.
In the 3- to 6-month-old group, amoxicillin was pre-
scribed for 75.2%, and its contribution decreased in the
other age groups to 50.4% in the 4-year-olds. Clarithromycin
and azithromycin were also prescribed in the youngest age
groups, as was amoxicillin⁄clavulanic acid. The proportions
of these drugs increased with age.
From the prescriptions of the ﬁve most used drugs, 97.6%
were within the guidelines’ recommended dose range. Most
course lengths corresponded with the guidelines, although
azithromycin, clarithromycin and cotrimoxazole were often
prescribed for a period longer than recommended.
Of the antibiotic prescriptions, 3.9%, mainly nitrofuran-
toin and trimethoprim, were in discordance with the drug’s
registration.
Distribution of prescriptions among age groups
We found that most antibiotics were prescribed for chil-
dren of 9–12 months of age. This differs from the studies by
Table 1 Number of prescriptions and percentage of total prescriptions of antibiotic drugs for different age categories
3–6 months 6–12 months 1 year 2 years 3 years 4 years
(N ¼ 2800) % (N ¼ 11 499) % (N ¼ 18 835) % (N ¼ 15 609) % (N ¼ 13 025) % (N ¼ 13 584) %
Amoxicillin 75.25 73.37 62.04 56.44 51.82 50.41
Clarithromycin 7.18 8.84 9.87 10.75 10.74 10.82
Amoxicillin⁄clavulanic acid 7.11 6.77 9.74 9.94 11.63 11.96
Small-spectrum penicillins 0.64 1.37 2.88 4.70 6.17 7.41
Trimethoprim 3.18 1.56 1.72 1.83 1.64 2.03
Cotrimoxazole 1.54 2.61 4.86 5.82 6.36 6.22
Azithromycin 1.14 1.86 4.35 5.17 5.79 5.51
Erythromycin 1.82 2.00 2.12 2.68 2.49 2.29
Nitrofurantoin 0.86 0.77 0.91 1.03 1.39 1.69
Cephalosporins 0.39 0.22 0.65 0.76 0.78 0.88
Miscellaneous 0.89 0.64 0.86 0.87 1.21 0.78
Beyond registration 7.14 4.64 3.19 3.34 3.76 4.20
Note: Black cells mean that the drugs are prescribed unregistered; grey cells mean that part of the prescriptions are prescribed, not registered.
Figure 2 Percentage of prescriptions of the ﬁve most used antibiotic drugs with
a dose within the recommended dose range (‘right’), above the maximum
dose (‘above max’) and under the minimum dose (‘under min’).
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age at 3–6 years, 1–2 years and 2–3 years, respectively. The
explanation for this difference could be that these studies
counted the children under 1 year as one group and did not
use the 3-month increments, as we did. Counting the pre-
scriptions in the whole group under 1 year, we also found
fewer prescriptions than the older groups. This could be
attributed to the lack of prescriptions in the group under
6 months, which hides the peak in the number of prescrip-
tions between 9 and 12 months. The other studies are per-
formed in other countries with other health systems. This
also could explain the difference.
Whenwe look atprevalence ﬁgures froma nationalDutch
survey of physicians in 2001 (20), infections such as otitis
or upper and lower respiratory infections were most com-
mon in children under 1 year of age in the Netherlands,
which explains the high antibiotic use. The low use of an-
tibiotics in children under 6 months of age was probably
because of the fact that those children are treated more of-
ten in hospital, and because this treatment is not visible
in a prescription database. The small increase we found
between 4- and 4.5-year-olds could be explained by the
fact that at that age, children begin primary school, which
means a change of environment and contact with new
germs.
Types of antibiotic drugs
Amoxicillin was prescribed mostly, especially in children
less than 1 year of age. But even in this age group, other
drugs were prescribed, such as clarithromycin and amoxi-
cillin with clavulanic acid. At an older age, the contribution
of other drugs increased. The amount of small-spectrum
antibiotics, although registered for this young age group,
increased, but did not exceed clarithromycin or amoxi-
cillin⁄clavulanic acid. In Scotland, among 0- to 4-year-olds,
erythromycin was used most, followed by amoxicillin (14).
In Denmark, 0- to 2-year-olds used mostly broad-spectrum
penicillins, but 3- to 6-year-olds used mostly penicillin V
(9). In Italy, they used broad-spectrum penicillins, amoxi-
cillin⁄clavulanic acid and cephalosporins; the contribution
of these drugs did not change a lot among the <1-year-olds,
the 2- to 4-year-olds and the 3- to 6-year-olds.
So, prescription preferences are quite different between
countries, as we found in our former study of 0- to 19-year-
olds (4).
Although, in Denmark and Italy, the ﬁrst choice corre-
sponding to the guidelines was, like in the Netherlands,
small-spectrum penicillins for respiratory infections, there
also were mainly broad-spectrum antibiotics and macrolides
prescribed in this agegroup.
Dose examination
A dose examination, like in this study, was performed in the
Scottishstudy(14).Thisstudy useddata fromGPsandfound
that 11.8% of the 0- to 4-year-old children were prescribed a
lower than recommended dose, and 2.5% were prescribed a
higherthanrecommendeddose. Wefoundthat,respectively,
2.0% and 0.4% of the prescriptions had a lower and higher
dose than recommended. Apparently, they found more in-
correct doses than we did. Because these are data obtained
from GPs by questionnaires, there was probably more infor-
mation available about the real weight of the patient and the
indication, which we lacked and which caused in our study
an underestimation of the number of incorrect doses. The
fact that they found much higher rates of incorrect doses
conﬁrms the underestimation we probably made.
Cotrimoxazole was prescribed more often in too low
doses, probably because it was prescribed more prophylacti-
cally. In the Netherlands, chronic medication is started with
a prescription for 14 days, so a 14-day prescription of pro-
phylaxis could be included in the analysis.
It was remarkable that specialists more often prescribed a
too low or a too high dose.
Specialists see more patients with special indications or
deviant weights. These could be pre-mature children, who
need adjusted doses, or children with serious infections or
uncommon bacteria, who need higher doses then usually
prescribed. This could explain why more doses were not
corresponding with the guidelines.
Prescribing outside the marketing authorization
The off-label and unlicensed prescribing in this study were of
nitrofurantoin, trimethoprim, azitromycin, tetracycline and
ciproﬂoxacin. In the 0- to 4-year-olds, nitrofurantoin and
trimethoprim were mainly used as a pharmacy-based for-
mulation, which means unlicensed. According to the Dutch
guidelines for urinary tract infections in such young chil-
dren (18), the ﬁrst choice should be amoxicillin⁄clavulanic
acid or cotrimoxazole. These special cases might be treated
by paediatricians. According to the prescription database,
indeed nitrofurantoin and trimethoprim were less often pre-
scribed by GPs. But, still more than half of the prescriptions
were from GPs.
Azithromycin, which is not registered for use in under
1-year-olds, was prescribed 246 times in this age group,
even though clarithromycin is a registered alternative. Al-
thoughtheconvenientdosagesystemmightcontributetothe
motivation of prescribing, it is remarkable that 206 (84%)
oftheseprescriptionswereprescribedbyaGP.
Tetracycline is contra-indicated in children under 8 years
of age for oral as well for local use because of binding on
teeth and bone and causing bone growth retardation. How-
ever, we found 190 prescriptions of pharmacy-based for-
mulations with tetracycline. These were probably drugs for
cutaneous use.
Ciproﬂoxacin is the ﬁfth drug that was prescribed beyond
its registration. It is only licensed in children older than 5
years and only with an indication for cystic ﬁbrosis. There-
fore, prescribing should be restricted to paediatricians. How-
ever, 88 (44%) of our 199 prescriptions were prescribed by
a GP.
Nevertheless, it was not known how many prescriptions
from GPs are continuations of prescriptions ﬁrst made by
specialists or were prescribed by order of a specialist.
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As far as we know, there are no other epidemiological stud-
ies of course lengths of antibiotics in children. Figure 3
shows that most course lengths corresponded with the
guidelines.
Amoxicillin and amoxicillin with clavulanic acid are
mostly prescribed for 7 days.
Azithromycin courses are mainly recommended for 3 days
by the guidelines (12,13,18). However, there are also many
courses longer than 3 days, even beyond the maximum of 5
days. The content of the packaging could be because of this.
This is probably also the explanation why clarithromycin
was so oftenprescribed for 12days.
For clarithromycin, a dose length of 5–10 days is recom-
mended for most indications. The suspension is packaged in
bottles of 60 mL, enough for 6 days, while the usual dosage
is 10 mL per day in two doses. It is common practice in the
Dutch pharmacies that bottles are not partly delivered, so
when a course of, for example, 7 days is needed, two bottles
(120 mL) are delivered with the advice to throw away the
rest. This wastes medicine and also increases the risk that
the child takes by accident a longer course than was meant,
which contributes to antibiotic resistance.
Cotrimoxazole was prescribed many times for more than
the maximal course length, which is 10 days. It was probably
prescribed more often in a prophylactic way than the other
antibiotic drugs.
Strengths and limitations
The strength of this study was that data were obtained from
daily practice, in which the physician, the pharmacist and
the patient were not aware of participation in a study. Also,
the large size of the database provided power to the results.
One of the limitations was that the indications for pre-
scription were not known, because this information was not
available to the pharmacy. Also, we did not know whether
the patient actually used the medication at home.
The number of incorrect doses may be underestimated, as
mentioned above. The dose range we used, being calculated
for every single age group for the ﬁve most used drugs, was
quite wide. We did not know the exact weight of the children
or the indication or, for example, whether a maximum dose
in a certain case was really necessary. So, the prescriptions
within therecommendeddose rangecould stillcontain cases
inwhich an incorrectdose was prescribed.
CONCLUSION
According to this study, most antibiotic courses for chil-
dren between 0 and 4 years of age have the correct dose
(97.6%), the correct length and are registered for this age
(96.1%). Nevertheless, the prescriptions do not correspond
with the guidelines. Small-spectrum antibiotics, which are
recommended for respiratory infections (being one of the
common infections) and are registered for this age, are not
often prescribed. And although there are enough alterna-
tives, unlicensed and off-label prescribing occurs, especially
in the most vulnerable group of under 1 year of age, which
uses the most antibiotic drugs.
ACKNOWLEDGEMENT
The study is supported by Apotheek Hardegarijp (Hardegar-
ijp Pharmacy) in cooperation with the University of Gronin-
gen.
FINANCIAL DISCLOSURE
All authors have no ﬁnancial relationships relevant to this
article.
CONFLICT OF INTEREST
None.
References
1. Sanz EJ. Drug prescribing for children in general practice.
Acta Paediatr 1998; 87: 489–90.
2. Schirm E, van-den-Berg PB, Gebben H, Sauer P, de Jong-van
den Berg LTW. Drug use of children in the community
assessed through pharmacy dispensing data. Br J Clin
Pharmacol 2000; 50: 473–8.
3. Thrane N, Sorensen HT. A one-year population-based study of
drug prescriptions for Danish children. Acta Paediatr 1999;
88: 1131–6.
4. de Jong J, van den Berg PB, de Vries TW, de Jong-van den
Berg LTW. Antibiotic drug use of children in the Netherlands
from 1999 till 2005. Eur J Clin Pharmacol 2008; 64: 913–19.
5. Johnson TN. The problems in scaling adult drug doses to
children. Arch Dis Child 2008; 93: 207–11.
6. Borgnolo G, Simon G, Francescutti C, Lattuada L, Zanier L.
Antibiotic prescription in Italian children: a population-based
study in Friuli Venezia Giulia, north-east Italy. Acta Paediatr
2001; 90: 1316–20.
7. Headley J, Northstone K. Medication administered to children
from 0 to 7.5 years in the Avon Longitudinal Study of Parents
and Children (ALSPAC). Eur J Clin Pharmacol 2007; 63:
189–95.
8. Schindler C, Krappweis J, Morgenstern I, Kirch W.
Prescriptions of systemic antibiotics for children in Germany
aged between 0 and 6 years. Pharmacoepidemiol Drug Saf
2003; 12: 113–20.
9. Thrane N, Steffensen FH, Mortensen JT, Schonheyder HC,
Sorensen HT. A population-based study of antibiotic
prescriptions for Danish children. Pediatr Infect Dis J 1999;
18: 333–7.
10. Schirm E, Tobi H, de Jong-van den Berg LTW. Risk factors for
unlicensed and off-label drug use in children outside the
hospital. Pediatrics 2003; 111: 291–5.
11. ‘t Jong GW, Eland IA, Sturkenboom MC, van den Anker JN,
Stricker BH. Unlicensed and off label prescription of drugs to
children: population based cohort study. BMJ 2002; 324: 1313–
14.
12. Nederlands Kenniscentrum voor Farmacotherapie bij Kinderen
Kinderformularium. Available at:
http://www.kinderformularium.nl (accessed 4 July, 2008).
13. Nederlandse Vereniging van Kinderartsen. Blauwdruk
pediatrische antimicrobie ¨le therapie, 2e herziene druk. Utrecht:
Nederlandse Vereniging van Kinderartsen, 2001.
14. Ekins Daukes S, McLay JS, Taylor MW, Simpson CR, Helms
PJ. Antibiotic prescribing for children. Too much and too little?
Retrospective observational study in primary care. Br J Clin
Pharmacol 2003; 56: 92–5.
de Jong et al. Antibiotic usage, dosage and course length in infants
ª2009 The Author(s)/Journal Compilation ª2009 Foundation Acta Pædiatrica/Acta Pædiatrica 2009 98, pp. 1142–1148 114715. Monster TB, Janssen WM, de Jong PE, de Jong-van den Berg
LT. Pharmacy data in epidemiological studies: an easy to obtain
and reliable tool. Pharmacoepidemiol Drug Saf 2002; 11: 379–
84.
16. WHO Collaborating Centre for Drug Statistic Methodology.
Guidelines for ATC classiﬁcation and DDD assignment. Oslo:
World Health Organization.
17. Fredriks AM, van Buuren S, Burgmeijer RJ, Meulmeester JF,
Beuker RJ, Brugman E, et al. Continuing positive secular
growth change in The Netherlands 1955–1997. Pediatr Res
2000; 47: 316–23.
18. Nederlands Huisartsen Genootschap. NHG standaarden
divers. Utrecht: Nederlands Huisartsen Genootschap,
2007.
19. Centraal College ter Beoordeling vanGeneesmiddelen.
Summary of product characteristics. Available at: http://www
cbg-meb nl (accessed August 29, 2008).
20. van der Linden MW, van Suijlekom Smit LW, Schellevis FG,
van der Wouden JC. Tweede nationale studie naar ziekten en
verrichting in de huisartsenpraktijk; het kind in de
huisartsenpraktijk. Rotterdam: Afdeling
Huisartsgeneeskunde, Erasmus MC, 2005.
21. de Jong J, van den Berg PB, de Vries TW, de Jong-van den Berg
LTW. Antibiotic drug use of children in the Netherlands from
1999 till 2005. Eur J Clin Pharmacol 2008; 64: 913–19.
Antibiotic usage, dosage and course length in infants de Jong et al.
1148 ª2009 The Author(s)/Journal Compilation ª2009 Foundation Acta Pædiatrica/Acta Pædiatrica 2009 98, pp. 1142–1148